EP3148336
ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.5.2015EP published:
2.10.2019EP application number:
15799685.1
EPO information:
European Patent Register
Max expiry date:
27.5.2035
Title:
ERIBULIN AND POLY (ADP RIBOSE) POLYMERASE (PARP) INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER
Timeline
Today
28.5.2015EP application
2.10.2019EP Publication
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
6-10, Koishikawa 4-chome Bunkyo-ku, 112-8088, Tokyo, JP
Inventor
Name:
COX, DavidAddress:
Wayne, NJ, US
Name:
KREMER, AltonAddress:
Weston, CT, US
Name:
MCGONIGLE, SharonAddress:
Andover, MA, US
Name:
WU, JiayiAddress:
Brookline, MA, US
Priority
Number:
201462003798 PDate:
28.5.2014Country:
US
Number:
201462088200 PDate:
5.12.2014Country:
US
Classification
Categories:
A61K 31/357, A61K 31/519, A61K 31/555, A01N 43/58, A61K 45/06, A61P 35/00